Utilization of Machine Learning in the Prediction, Diagnosis, Prognosis, and Management of Chronic Myeloid Leukemia

Area of Science:

• Hematology
• Bioinformatics
• Artificial Intelligence in Medicine

Background:

• Chronic myeloid leukemia (CML) is a clonal hematologic disorder defined by the Philadelphia chromosome and BCR::ABL1 fusion protein.
• Integrating diverse data types (molecular, genetic, clinical, laboratory) is crucial for enhancing CML diagnosis, prognosis, and treatment prediction.
• Managing the complexity and volume of CML data necessitates advanced computational support, such as artificial intelligence.

Purpose of the Study:

• To provide an overview of recent research utilizing machine learning algorithms for chronic myeloid leukemia patient management.
• To highlight the potential benefits and drawbacks of applying machine learning in therapeutic contexts for CML.
• To explore how machine learning can advance precision treatment by integrating clinical, genetic, and laboratory data.

Main Methods:

• Review of recent scientific literature on machine learning applications in chronic myeloid leukemia.
• Analysis of specific machine learning models and algorithms used in CML research.
• Evaluation of the integration of clinical, genetic, and laboratory data with machine learning approaches.

Main Results:

• Machine learning demonstrates significant potential for improving the diagnostic, prognostic, and predictive accuracy in CML.
• The combination of clinical and genetic data with laboratory testing, powered by machine learning, can advance precision treatment.
• Overcoming current obstacles in CML research is possible through these advanced computational instruments.

Conclusions:

• Machine learning offers a powerful tool to unravel the complexities of CML, paving the way for a new era in patient-centered hematology care.
• Adoption of machine learning can lead to improved diagnosis accuracy, sophisticated risk assessment, and customized treatment plans for CML patients.
• The integration of machine learning with comprehensive patient data is key to unlocking advancements in precision medicine for chronic myeloid leukemia.